ArticleHaematologica2026

Diabetes mellitus and diabetes-related complications are common in patients with myelodysplastic syndromes but Hemoglobin A1C is an inadequate marker.

Ariel Israel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.